Functional evaluation of the autoimmunity-associated CTLA4 gene: The effect of the (AT) repeat in the 3′untranslated region (UTR)

Journal of Autoimmunity

Volumn 27, Issue 2, 2006, Pages 105-109

  Anjos, Suzana M ^a   Polychronakos, Constantin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

+49A G; +6230G A; CTLA4; Genetics of diabetes; Microsatellite repeat; Regulatory polymorphism; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACTINOMYCIN; DNA; MESSENGER RNA;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; STEADY STATE; VALIDATION PROCESS;

3' UNTRANSLATED REGIONS; ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DINUCLEOTIDE REPEATS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER;

EID: 33749529898     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.06.004     Document Type: Article

References (19)

1. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5 (1996) 1075-1080
2. Marron M.P., Raffel L.J., Garchon H.J., Jacob C.O., Serrano-Rios M., Martinez Larrad M.T., et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6 (1997) 1275-1282
3. Van der Auwera B.J., Vandewalle C.L., Schuit F.C., Winnock F., De Leeuw I.H., Van Imschoot S., et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin Exp Immunol 110 (1997) 98-103
4. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
5. Marron M.P., Zeidler A., Raffel L.J., Eckenrode S.E., Yang J.J., Hopkins D.I., et al. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49 (2000) 492-499
6. Anjos S.M., Shao W., Marchand L., and Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3′+6230G>A polymorphism. Genes Immun 6 (2005) 305-311
7. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.C., and Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277 (2002) 46478-46486
8. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., and DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165 (2000) 6606-6611
9. Maurer M., Loserth S., Kolb-Maurer A., Ponath A., Wiese S., Kruse N., et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 + 49) alters T-cell activation. Immunogenetics 54 (2002) 1-8
10. Anjos S.M., Tessier M.C., and Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab 89 (2004) 6257-6265
11. Braun J., Donner H., Siegmund T., Walfish P.G., Usadel K.H., and Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51 (1998) 563-566
12. Lee Y.J., Lo F.S., Shu S.G., Wang C.H., Huang C.Y., Liu H.F., et al. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14 (2001) 383-388
13. Ihara K., Ahmed S., Nakao F., Kinukawa N., Kuromaru R., Matsuura N., et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53 (2001) 447-451
14. Wang X.B., Zhao X., Giscombe R., and Lefvert A.K. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 3 (2002) 233-234
15. Kemp E.H., Ajjan R.A., Husebye E.S., Peterson P., Uibo R., Imrie H., et al. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin Endocrinol (Oxf) 49 (1998) 609-613
16. Bevilacqua A., Ceriani M.C., Capaccioli S., and Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195 (2003) 356-372
17. Holopainen P.M., and Partanen J.A. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 167 (2001) 2457-2458
18. Wang X.B., Kakoulidou M., Giscombe R., Qiu Q., Huang D., Pirskanen R., et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 130 (2002) 224-232
19. Pastinen T., and Hudson T.J. Cis-acting regulatory variation in the human genome. Science 306 (2004) 647-650